Roche Holding AG Share Price London S.E.
Stocks
0QOK
CH0012032048
Pharmaceuticals
OTC Markets Traded|
Market Closed -
London S.E.
08:50:00 10/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 323.90 CHF | 0.00% |
|
0.00% | -1.29% |
| 03/09 | Hutchmed Enters Licensing Agreement With GSK for Cancer Drug | DJ |
| 02/09 | Roche, Treeline Biosciences to Evaluate Combination Therapy for B-cell Lymphomas | MT |
| Market Cap | 28TCr 34TCr 29TCr 25TCr 47TCr 32,52500Cr 47TCr 3,28800Cr 1,26500Cr 16,49700Cr 1,27700Cr 1,25000Cr 52,39900Cr | P/E 2026 * |
18.9x | P/E 2027 * | 17.1x |
|---|---|---|---|---|---|
| Enterprise Value | 29TCr 35TCr 30TCr 26TCr 49TCr 33,80500Cr 49TCr 3,41700Cr 1,31500Cr 17,14700Cr 1,32800Cr 1,29900Cr 54,46200Cr | EV / Sales 2026 * |
4.58x | EV / Sales 2027 * | 4.28x |
| Free-Float |
88.78% | Yield 2026 * |
2.88% | Yield 2027 * | 2.95% |
Last Transcript : Roche Holding AG
| 1 day | +6.75% | ||
| Current month | +0.48% | ||
| 6 months | -3.39% | ||
| Current year | -1.29% |
| Current year | 311.6 |  | 377 |
| 1 year | 252.3 | | 377 |
| 3 years | 212.3 | | 377 |
| 5 years | 212.3 | | 404.1 |
| 10 years | 202.23 | | 404.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 51 | 15/03/2023 | |
Alan Hippe
DFI | Director of Finance/CFO | 59 | 06/06/2011 |
| Chief Operating Officer | - | 01/10/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
André Hoffmann
BRD | Director/Board Member | 68 | 01/01/1996 |
Severin Schwan
CHM | Chairman | 59 | 15/03/2023 |
| Director/Board Member | 73 | 03/03/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | - | - | 34TCr | |
| -0.11% | -3.16% | +48.82% | +88.56% | 1,00200Cr | |
| -0.27% | -4.34% | +51.52% | +63.75% | 64TCr | |
| +1.63% | -2.00% | +20.49% | +71.10% | 44TCr | |
| -0.63% | -1.06% | +28.11% | +34.59% | 34TCr | |
| +0.43% | -14.61% | +9.88% | +27.26% | 26TCr | |
| +0.93% | -1.82% | -1.82% | +8.41% | 24TCr | |
| -2.25% | -13.88% | +37.33% | +46.14% | 21TCr | |
| -0.90% | -5.09% | -15.47% | -57.75% | 20TCr | |
| -0.58% | -4.24% | +25.65% | +87.97% | 18TCr | |
| Average | +0.67% | -5.00% | +22.72% | +41.11% | 39.22TCr | |
| Weighted average by Cap. | +0.85% | -4.24% | +31.84% | +55.68% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.26TCr 7.72TCr 6.64TCr 5.71TCr 11TCr 7,38200Cr 11TCr 75TCr 29TCr 3,74400Cr 29TCr 28TCr 11,89200Cr | 6.55TCr 8.07TCr 6.94TCr 5.96TCr 11TCr 7,71300Cr 11TCr 78TCr 30TCr 3,91200Cr 30TCr 30TCr 12,42600Cr |
| Net income | 1.45TCr 1.79TCr 1.54TCr 1.32TCr 2.47TCr 1,70800Cr 2.49TCr 17TCr 6.64TCr 87TCr 6.71TCr 6.56TCr 2,75200Cr | 1.63TCr 2.01TCr 1.73TCr 1.49TCr 2.78TCr 1,92300Cr 2.8TCr 19TCr 7.48TCr 98TCr 7.55TCr 7.39TCr 3,09700Cr |
| Net Debt | 1.09TCr 1.34TCr 1.15TCr 990.02Cr 1.85TCr 1,28000Cr 1.87TCr 13TCr 4.98TCr 65TCr 5.03TCr 4.92TCr 2,06300Cr | 401.86Cr 495.25Cr 425.91Cr 366.09Cr 684.36Cr 47TCr 690.57Cr 4.79TCr 1.84TCr 24TCr 1.86TCr 1.82TCr 76TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/26/10 | CHF 323.90 | 0.00% | 60,601 |
| 09/26/09 | CHF 323.90 | 0.00% | 39,835 |
| 08/26/08 | CHF 323.90 | 0.00% | 1,20,626 |
| 07/26/07 | CHF 323.90 | 0.00% | 185 |
| 04/26/04 | CHF 323.90 | 0.00% | 7,764 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ROP Stock
- 0QOK Stock
Select your edition
All financial news and data tailored to specific country editions
